Post-Merger Tilray Stock Is One To Keep On Your Watchlist for Now

InvestorPlace2021-05-13

More consolidation and regulatory changes are likely coming to the volatile cannabis sector. Can Canadian cannabis producerTilray(NASDAQ:TLRY) get its mojo back? Once-hot TLRY stock is down more than...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（5）

Troedas
·2021-05-14
Yeah
Reply
1
Report
TriciaLxy
·2021-05-13
Comment and like pls
Reply
2
Report
Fold Replies
- Wandakdash:
  Naise
  2021-06-27
  Reply
  Report
Ahliangteh
·2021-05-13
Ok
Reply
1
Report
Fold Replies
- Ahliangteh:
  Ok
  2021-05-13
  Reply
  Report
- hitithard:
  Comment on my comment
  2021-05-13
  Reply
  Report
Troedas
·2021-05-13
Comment and like please. Thank you
Reply
3
Report
FlyHighFly
·2021-05-13
Like please
Reply
2
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1108721806?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-05-13 17:56","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1108721806","market":"us","top_or_hot":-1,"title":"Post-Merger Tilray Stock Is One To Keep On Your Watchlist for Now","media":"InvestorPlace","content":"<div>\n<p>More consolidation and regulatory changes are likely coming to the volatile cannabis sector.\n\nCan Canadian cannabis producerTilray(NASDAQ:TLRY) get its mojo back? Once-hot TLRY stock is down more than...</p>\n\n<a href=\"https://investorplace.com/2021/05/post-merger-tilray-stock-is-one-to-keep-on-your-watchlist-for-now/\">Source Link</a>\n\n</div>\n","source":"lsy1606302653667","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Post-Merger Tilray Stock Is One To Keep On Your Watchlist for Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPost-Merger Tilray Stock Is One To Keep On Your Watchlist for Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-13 17:56 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/05/post-merger-tilray-stock-is-one-to-keep-on-your-watchlist-for-now/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>More consolidation and regulatory changes are likely coming to the volatile cannabis sector.\n\nCan Canadian cannabis producerTilray(NASDAQ:TLRY) get its mojo back? Once-hot TLRY stock is down more than...</p>\n\n<a href=\"https://investorplace.com/2021/05/post-merger-tilray-stock-is-one-to-keep-on-your-watchlist-for-now/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TLRY","symbol_name":"Tilray Inc.","start_time":0,"source_url":"https://investorplace.com/2021/05/post-merger-tilray-stock-is-one-to-keep-on-your-watchlist-for-now/","article_id":"1108721806","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1108721806","pubTimestamp":1620899790,"sourceInfo":{"source_id":"lsy1606302653667","name":"InvestorPlace"},"weMediaInfo":null,"summary":"More consolidation and regulatory changes are likely coming to the volatile cannabis sector.\n\nCan Ca","collect":0,"end_time":0,"defaultTopTitle":"investorplace.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"TLRY":"Tilray Inc."},"translate_title":"合并后的Tilray股票是一个保持在你的观察名单上现在","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TLRY":0.9},"content_text":"More consolidation and regulatory changes are likely coming to the volatile cannabis sector.\n\nCan Canadian cannabis producerTilray(NASDAQ:TLRY) get its mojo back? Once-hot TLRY stock is down more than 62% over the past three months, compared to the 16.9% decline for pot sector trackerETFMG Alternative Harvest ETF(NYSEARCA:MJ). The shares are the top holding in the exchange-traded fund’s (ETF) 31-stock portfolio.\nInvestors are hoping that the Toronto-based company can finally turn itself around now that it is officially the biggest Canadian marijuana producer following thecompletion of its mergerwith former rival Aphria.\nThe newly merged company, which retains the Tilray name and brand, is now larger than other major cannabis companies such asCanopy Growth(NASDAQ:CGC) andAurora Cannabis(NYSE:ACB) with annual revenues approaching $1 billion and a 17% share of the North American retail cannabis market.\nAs the recreational cannabis space continues to evolve, mature and consolidate, shareholders are expecting the newly reinforced Tilray to not only survive but to thrive.\nTLRY Stock Highs and Lows\nThe completed merger with Aphria has given Tilray and its stock a much needed lift. TLRY stock popped 14% immediately following news that the merger had successfully concluded and investment bankJefferies Groupimmediatelyupgraded the company’s sharesto “buy” from “underperform,” calling the merger with Aphria a “perfect match” and stating that Tilray has excellent upside potential in terms of future sales in the U.S., Canada and Europe.\nThe positive response to the merger was welcome by Tilray shareholders who have been on a wild ride with the stock so far this year. In early February, TLRY stock was targeted for ashort squeezeby the retail investors who commiserate on Reddit. In a concerted effort, they drove Tilray’s share price up 253%, from $25.77 on Jan. 29 to a peak of $90.99 on Feb. 10. The stock was back down to $30 a share by March 5 and today trades at $14.53.\nSadly, this was not the first time Tilray stock had gotten caught in a short squeeze. The same thinghappened in 2018, when the share price was driven 1,400% higher.\nTargeting U.S. Market\nPost-merger, Tilray is now being run by the senior leadership team that previously ran Aphria. While the merged company retains the Tilray name, it is now former Aphria CEO Irwin Simon running the show. Former Tilray CEO Brendan Kennedy has relinquished his management role and now serves only on the company’s board of directors.\nMoving forward, Tilray has said its immediate priorities are to finalize the merger internally and to focus its sales efforts onthe U.S. market, where it sees a huge opportunity.\nSimon has said Tilray’s ambition is to eventually control 30% of the North American cannabis market. With moreU.S. states legalizing cannabis(18 states in total have now legalized the drug for recreational use) and hope that the Biden administration may legalize the recreational drug at the federal level, Tilray is eager to expand in the U.S. with an array of products that include cannabis-infused beverages and edibles.\nOutside of North America, the company is expanding its presence in markets such as Germany andentering new marketswhere personal use has been decriminalized, such asIsraeland Portugal.\nMuch of Tilray’s international expansion focuses on a mix of recreational and medicinal cannabis products.\nNot Yet Stable Investment\nA lot continues to happen in the cannabis space and there’s no question that Tilray is a stronger and more resilient company after its merger with Aphria. However, the cannabis sector continues toevolve and changerapidly. A lot still needs to happen before cannabis can be considered a stable and mature investment. And this fact is reflected in TLRY stock, which continues to hover around $15 and struggles to stay above the $20 per share threshold.\nWhile some investors have upgraded Tilray’s shares in recent weeks, others havedowngraded the stock, stating that the merger and the company’s current market share are already baked into the stock price.\nThe company’s earnings alsocontinue to disappointinvestors and analysts. Given that more consolidation and regulatory changes are likely in the broader cannabis sector, investors would be smart to keep TLRY stock on their watchlist for now and be ready to buy shares quickly if it looks like a legitimate breakout occurs.\nOn the date of publication, Joel Baglole did not have (either directly or indirectly) any positions in the securities mentioned in this article.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":198811906,"gmtCreate":1620950567305,"gmtModify":1704350909384,"author":{"id":"3559088164596385","authorId":"3559088164596385","name":"Troedas","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":5,"crmLevelSwitch":0},"htmlText":"Yeah","listText":"Yeah","text":"Yeah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/198811906","repostId":1108721806,"repostType":2,"repost":{"id":"1108721806","pubTimestamp":1620899790,"share":"https://www.laohu8.com/m/news/1108721806?lang=&edition=full","pubTime":"2021-05-13 17:56","market":"us","language":"en","title":"Post-Merger Tilray Stock Is One To Keep On Your Watchlist for Now","url":"https://stock-news.laohu8.com/highlight/detail?id=1108721806","media":"InvestorPlace","summary":"More consolidation and regulatory changes are likely coming to the volatile cannabis sector.\n\nCan Ca","content":"<blockquote>\n <b>More consolidation and regulatory changes are likely coming to the volatile cannabis sector.</b>\n</blockquote>\n<p>Can Canadian cannabis producer<b>Tilray</b>(NASDAQ:<b><u>TLRY</u></b>) get its mojo back? Once-hot TLRY stock is down more than 62% over the past three months, compared to the 16.9% decline for pot sector tracker<b>ETFMG Alternative Harvest ETF</b>(NYSEARCA:<b><u>MJ</u></b>). The shares are the top holding in the exchange-traded fund’s (ETF) 31-stock portfolio.</p>\n<p>Investors are hoping that the Toronto-based company can finally turn itself around now that it is officially the biggest Canadian marijuana producer following thecompletion of its mergerwith former rival Aphria.</p>\n<p>The newly merged company, which retains the Tilray name and brand, is now larger than other major cannabis companies such as<b>Canopy Growth</b>(NASDAQ:<b><u>CGC</u></b>) and<b>Aurora Cannabis</b>(NYSE:<b><u>ACB</u></b>) with annual revenues approaching $1 billion and a 17% share of the North American retail cannabis market.</p>\n<p>As the recreational cannabis space continues to evolve, mature and consolidate, shareholders are expecting the newly reinforced Tilray to not only survive but to thrive.</p>\n<p><b>TLRY Stock Highs and Lows</b></p>\n<p>The completed merger with Aphria has given Tilray and its stock a much needed lift. TLRY stock popped 14% immediately following news that the merger had successfully concluded and investment bank<b>Jefferies Group</b>immediatelyupgraded the company’s sharesto “buy” from “underperform,” calling the merger with Aphria a “perfect match” and stating that Tilray has excellent upside potential in terms of future sales in the U.S., Canada and Europe.</p>\n<p>The positive response to the merger was welcome by Tilray shareholders who have been on a wild ride with the stock so far this year. In early February, TLRY stock was targeted for ashort squeezeby the retail investors who commiserate on Reddit. In a concerted effort, they drove Tilray’s share price up 253%, from $25.77 on Jan. 29 to a peak of $90.99 on Feb. 10. The stock was back down to $30 a share by March 5 and today trades at $14.53.</p>\n<p>Sadly, this was not the first time Tilray stock had gotten caught in a short squeeze. The same thinghappened in 2018, when the share price was driven 1,400% higher.</p>\n<p><b>Targeting U.S. Market</b></p>\n<p>Post-merger, Tilray is now being run by the senior leadership team that previously ran Aphria. While the merged company retains the Tilray name, it is now former Aphria CEO Irwin Simon running the show. Former Tilray CEO Brendan Kennedy has relinquished his management role and now serves only on the company’s board of directors.</p>\n<p>Moving forward, Tilray has said its immediate priorities are to finalize the merger internally and to focus its sales efforts onthe U.S. market, where it sees a huge opportunity.</p>\n<p>Simon has said Tilray’s ambition is to eventually control 30% of the North American cannabis market. With moreU.S. states legalizing cannabis(18 states in total have now legalized the drug for recreational use) and hope that the Biden administration may legalize the recreational drug at the federal level, Tilray is eager to expand in the U.S. with an array of products that include cannabis-infused beverages and edibles.</p>\n<p>Outside of North America, the company is expanding its presence in markets such as Germany andentering new marketswhere personal use has been decriminalized, such asIsraeland Portugal.</p>\n<p>Much of Tilray’s international expansion focuses on a mix of recreational and medicinal cannabis products.</p>\n<p><b>Not Yet Stable Investment</b></p>\n<p>A lot continues to happen in the cannabis space and there’s no question that Tilray is a stronger and more resilient company after its merger with Aphria. However, the cannabis sector continues toevolve and changerapidly. A lot still needs to happen before cannabis can be considered a stable and mature investment. And this fact is reflected in TLRY stock, which continues to hover around $15 and struggles to stay above the $20 per share threshold.</p>\n<p>While some investors have upgraded Tilray’s shares in recent weeks, others havedowngraded the stock, stating that the merger and the company’s current market share are already baked into the stock price.</p>\n<p>The company’s earnings alsocontinue to disappointinvestors and analysts. Given that more consolidation and regulatory changes are likely in the broader cannabis sector, investors would be smart to keep TLRY stock on their watchlist for now and be ready to buy shares quickly if it looks like a legitimate breakout occurs.</p>\n<p><i>On the date of publication, Joel Baglole did not have (either directly or indirectly) any positions in the securities mentioned in this article.</i></p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Post-Merger Tilray Stock Is One To Keep On Your Watchlist for Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPost-Merger Tilray Stock Is One To Keep On Your Watchlist for Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-13 17:56 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/05/post-merger-tilray-stock-is-one-to-keep-on-your-watchlist-for-now/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>More consolidation and regulatory changes are likely coming to the volatile cannabis sector.\n\nCan Canadian cannabis producerTilray(NASDAQ:TLRY) get its mojo back? Once-hot TLRY stock is down more than...</p>\n\n<a href=\"https://investorplace.com/2021/05/post-merger-tilray-stock-is-one-to-keep-on-your-watchlist-for-now/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TLRY":"Tilray Inc."},"source_url":"https://investorplace.com/2021/05/post-merger-tilray-stock-is-one-to-keep-on-your-watchlist-for-now/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1108721806","content_text":"More consolidation and regulatory changes are likely coming to the volatile cannabis sector.\n\nCan Canadian cannabis producerTilray(NASDAQ:TLRY) get its mojo back? Once-hot TLRY stock is down more than 62% over the past three months, compared to the 16.9% decline for pot sector trackerETFMG Alternative Harvest ETF(NYSEARCA:MJ). The shares are the top holding in the exchange-traded fund’s (ETF) 31-stock portfolio.\nInvestors are hoping that the Toronto-based company can finally turn itself around now that it is officially the biggest Canadian marijuana producer following thecompletion of its mergerwith former rival Aphria.\nThe newly merged company, which retains the Tilray name and brand, is now larger than other major cannabis companies such asCanopy Growth(NASDAQ:CGC) andAurora Cannabis(NYSE:ACB) with annual revenues approaching $1 billion and a 17% share of the North American retail cannabis market.\nAs the recreational cannabis space continues to evolve, mature and consolidate, shareholders are expecting the newly reinforced Tilray to not only survive but to thrive.\nTLRY Stock Highs and Lows\nThe completed merger with Aphria has given Tilray and its stock a much needed lift. TLRY stock popped 14% immediately following news that the merger had successfully concluded and investment bankJefferies Groupimmediatelyupgraded the company’s sharesto “buy” from “underperform,” calling the merger with Aphria a “perfect match” and stating that Tilray has excellent upside potential in terms of future sales in the U.S., Canada and Europe.\nThe positive response to the merger was welcome by Tilray shareholders who have been on a wild ride with the stock so far this year. In early February, TLRY stock was targeted for ashort squeezeby the retail investors who commiserate on Reddit. In a concerted effort, they drove Tilray’s share price up 253%, from $25.77 on Jan. 29 to a peak of $90.99 on Feb. 10. The stock was back down to $30 a share by March 5 and today trades at $14.53.\nSadly, this was not the first time Tilray stock had gotten caught in a short squeeze. The same thinghappened in 2018, when the share price was driven 1,400% higher.\nTargeting U.S. Market\nPost-merger, Tilray is now being run by the senior leadership team that previously ran Aphria. While the merged company retains the Tilray name, it is now former Aphria CEO Irwin Simon running the show. Former Tilray CEO Brendan Kennedy has relinquished his management role and now serves only on the company’s board of directors.\nMoving forward, Tilray has said its immediate priorities are to finalize the merger internally and to focus its sales efforts onthe U.S. market, where it sees a huge opportunity.\nSimon has said Tilray’s ambition is to eventually control 30% of the North American cannabis market. With moreU.S. states legalizing cannabis(18 states in total have now legalized the drug for recreational use) and hope that the Biden administration may legalize the recreational drug at the federal level, Tilray is eager to expand in the U.S. with an array of products that include cannabis-infused beverages and edibles.\nOutside of North America, the company is expanding its presence in markets such as Germany andentering new marketswhere personal use has been decriminalized, such asIsraeland Portugal.\nMuch of Tilray’s international expansion focuses on a mix of recreational and medicinal cannabis products.\nNot Yet Stable Investment\nA lot continues to happen in the cannabis space and there’s no question that Tilray is a stronger and more resilient company after its merger with Aphria. However, the cannabis sector continues toevolve and changerapidly. A lot still needs to happen before cannabis can be considered a stable and mature investment. And this fact is reflected in TLRY stock, which continues to hover around $15 and struggles to stay above the $20 per share threshold.\nWhile some investors have upgraded Tilray’s shares in recent weeks, others havedowngraded the stock, stating that the merger and the company’s current market share are already baked into the stock price.\nThe company’s earnings alsocontinue to disappointinvestors and analysts. Given that more consolidation and regulatory changes are likely in the broader cannabis sector, investors would be smart to keep TLRY stock on their watchlist for now and be ready to buy shares quickly if it looks like a legitimate breakout occurs.\nOn the date of publication, Joel Baglole did not have (either directly or indirectly) any positions in the securities mentioned in this article.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":198998507,"gmtCreate":1620916920409,"gmtModify":1704350481280,"author":{"id":"3573228561771853","authorId":"3573228561771853","name":"TriciaLxy","avatar":"https://static.tigerbbs.com/4661ef5928b66dcac2a54d258319a065","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Comment and like pls","listText":"Comment and like pls","text":"Comment and like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/198998507","repostId":1108721806,"repostType":4,"repost":{"id":"1108721806","pubTimestamp":1620899790,"share":"https://www.laohu8.com/m/news/1108721806?lang=&edition=full","pubTime":"2021-05-13 17:56","market":"us","language":"en","title":"Post-Merger Tilray Stock Is One To Keep On Your Watchlist for Now","url":"https://stock-news.laohu8.com/highlight/detail?id=1108721806","media":"InvestorPlace","summary":"More consolidation and regulatory changes are likely coming to the volatile cannabis sector.\n\nCan Ca","content":"<blockquote>\n <b>More consolidation and regulatory changes are likely coming to the volatile cannabis sector.</b>\n</blockquote>\n<p>Can Canadian cannabis producer<b>Tilray</b>(NASDAQ:<b><u>TLRY</u></b>) get its mojo back? Once-hot TLRY stock is down more than 62% over the past three months, compared to the 16.9% decline for pot sector tracker<b>ETFMG Alternative Harvest ETF</b>(NYSEARCA:<b><u>MJ</u></b>). The shares are the top holding in the exchange-traded fund’s (ETF) 31-stock portfolio.</p>\n<p>Investors are hoping that the Toronto-based company can finally turn itself around now that it is officially the biggest Canadian marijuana producer following thecompletion of its mergerwith former rival Aphria.</p>\n<p>The newly merged company, which retains the Tilray name and brand, is now larger than other major cannabis companies such as<b>Canopy Growth</b>(NASDAQ:<b><u>CGC</u></b>) and<b>Aurora Cannabis</b>(NYSE:<b><u>ACB</u></b>) with annual revenues approaching $1 billion and a 17% share of the North American retail cannabis market.</p>\n<p>As the recreational cannabis space continues to evolve, mature and consolidate, shareholders are expecting the newly reinforced Tilray to not only survive but to thrive.</p>\n<p><b>TLRY Stock Highs and Lows</b></p>\n<p>The completed merger with Aphria has given Tilray and its stock a much needed lift. TLRY stock popped 14% immediately following news that the merger had successfully concluded and investment bank<b>Jefferies Group</b>immediatelyupgraded the company’s sharesto “buy” from “underperform,” calling the merger with Aphria a “perfect match” and stating that Tilray has excellent upside potential in terms of future sales in the U.S., Canada and Europe.</p>\n<p>The positive response to the merger was welcome by Tilray shareholders who have been on a wild ride with the stock so far this year. In early February, TLRY stock was targeted for ashort squeezeby the retail investors who commiserate on Reddit. In a concerted effort, they drove Tilray’s share price up 253%, from $25.77 on Jan. 29 to a peak of $90.99 on Feb. 10. The stock was back down to $30 a share by March 5 and today trades at $14.53.</p>\n<p>Sadly, this was not the first time Tilray stock had gotten caught in a short squeeze. The same thinghappened in 2018, when the share price was driven 1,400% higher.</p>\n<p><b>Targeting U.S. Market</b></p>\n<p>Post-merger, Tilray is now being run by the senior leadership team that previously ran Aphria. While the merged company retains the Tilray name, it is now former Aphria CEO Irwin Simon running the show. Former Tilray CEO Brendan Kennedy has relinquished his management role and now serves only on the company’s board of directors.</p>\n<p>Moving forward, Tilray has said its immediate priorities are to finalize the merger internally and to focus its sales efforts onthe U.S. market, where it sees a huge opportunity.</p>\n<p>Simon has said Tilray’s ambition is to eventually control 30% of the North American cannabis market. With moreU.S. states legalizing cannabis(18 states in total have now legalized the drug for recreational use) and hope that the Biden administration may legalize the recreational drug at the federal level, Tilray is eager to expand in the U.S. with an array of products that include cannabis-infused beverages and edibles.</p>\n<p>Outside of North America, the company is expanding its presence in markets such as Germany andentering new marketswhere personal use has been decriminalized, such asIsraeland Portugal.</p>\n<p>Much of Tilray’s international expansion focuses on a mix of recreational and medicinal cannabis products.</p>\n<p><b>Not Yet Stable Investment</b></p>\n<p>A lot continues to happen in the cannabis space and there’s no question that Tilray is a stronger and more resilient company after its merger with Aphria. However, the cannabis sector continues toevolve and changerapidly. A lot still needs to happen before cannabis can be considered a stable and mature investment. And this fact is reflected in TLRY stock, which continues to hover around $15 and struggles to stay above the $20 per share threshold.</p>\n<p>While some investors have upgraded Tilray’s shares in recent weeks, others havedowngraded the stock, stating that the merger and the company’s current market share are already baked into the stock price.</p>\n<p>The company’s earnings alsocontinue to disappointinvestors and analysts. Given that more consolidation and regulatory changes are likely in the broader cannabis sector, investors would be smart to keep TLRY stock on their watchlist for now and be ready to buy shares quickly if it looks like a legitimate breakout occurs.</p>\n<p><i>On the date of publication, Joel Baglole did not have (either directly or indirectly) any positions in the securities mentioned in this article.</i></p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Post-Merger Tilray Stock Is One To Keep On Your Watchlist for Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPost-Merger Tilray Stock Is One To Keep On Your Watchlist for Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-13 17:56 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/05/post-merger-tilray-stock-is-one-to-keep-on-your-watchlist-for-now/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>More consolidation and regulatory changes are likely coming to the volatile cannabis sector.\n\nCan Canadian cannabis producerTilray(NASDAQ:TLRY) get its mojo back? Once-hot TLRY stock is down more than...</p>\n\n<a href=\"https://investorplace.com/2021/05/post-merger-tilray-stock-is-one-to-keep-on-your-watchlist-for-now/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TLRY":"Tilray Inc."},"source_url":"https://investorplace.com/2021/05/post-merger-tilray-stock-is-one-to-keep-on-your-watchlist-for-now/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1108721806","content_text":"More consolidation and regulatory changes are likely coming to the volatile cannabis sector.\n\nCan Canadian cannabis producerTilray(NASDAQ:TLRY) get its mojo back? Once-hot TLRY stock is down more than 62% over the past three months, compared to the 16.9% decline for pot sector trackerETFMG Alternative Harvest ETF(NYSEARCA:MJ). The shares are the top holding in the exchange-traded fund’s (ETF) 31-stock portfolio.\nInvestors are hoping that the Toronto-based company can finally turn itself around now that it is officially the biggest Canadian marijuana producer following thecompletion of its mergerwith former rival Aphria.\nThe newly merged company, which retains the Tilray name and brand, is now larger than other major cannabis companies such asCanopy Growth(NASDAQ:CGC) andAurora Cannabis(NYSE:ACB) with annual revenues approaching $1 billion and a 17% share of the North American retail cannabis market.\nAs the recreational cannabis space continues to evolve, mature and consolidate, shareholders are expecting the newly reinforced Tilray to not only survive but to thrive.\nTLRY Stock Highs and Lows\nThe completed merger with Aphria has given Tilray and its stock a much needed lift. TLRY stock popped 14% immediately following news that the merger had successfully concluded and investment bankJefferies Groupimmediatelyupgraded the company’s sharesto “buy” from “underperform,” calling the merger with Aphria a “perfect match” and stating that Tilray has excellent upside potential in terms of future sales in the U.S., Canada and Europe.\nThe positive response to the merger was welcome by Tilray shareholders who have been on a wild ride with the stock so far this year. In early February, TLRY stock was targeted for ashort squeezeby the retail investors who commiserate on Reddit. In a concerted effort, they drove Tilray’s share price up 253%, from $25.77 on Jan. 29 to a peak of $90.99 on Feb. 10. The stock was back down to $30 a share by March 5 and today trades at $14.53.\nSadly, this was not the first time Tilray stock had gotten caught in a short squeeze. The same thinghappened in 2018, when the share price was driven 1,400% higher.\nTargeting U.S. Market\nPost-merger, Tilray is now being run by the senior leadership team that previously ran Aphria. While the merged company retains the Tilray name, it is now former Aphria CEO Irwin Simon running the show. Former Tilray CEO Brendan Kennedy has relinquished his management role and now serves only on the company’s board of directors.\nMoving forward, Tilray has said its immediate priorities are to finalize the merger internally and to focus its sales efforts onthe U.S. market, where it sees a huge opportunity.\nSimon has said Tilray’s ambition is to eventually control 30% of the North American cannabis market. With moreU.S. states legalizing cannabis(18 states in total have now legalized the drug for recreational use) and hope that the Biden administration may legalize the recreational drug at the federal level, Tilray is eager to expand in the U.S. with an array of products that include cannabis-infused beverages and edibles.\nOutside of North America, the company is expanding its presence in markets such as Germany andentering new marketswhere personal use has been decriminalized, such asIsraeland Portugal.\nMuch of Tilray’s international expansion focuses on a mix of recreational and medicinal cannabis products.\nNot Yet Stable Investment\nA lot continues to happen in the cannabis space and there’s no question that Tilray is a stronger and more resilient company after its merger with Aphria. However, the cannabis sector continues toevolve and changerapidly. A lot still needs to happen before cannabis can be considered a stable and mature investment. And this fact is reflected in TLRY stock, which continues to hover around $15 and struggles to stay above the $20 per share threshold.\nWhile some investors have upgraded Tilray’s shares in recent weeks, others havedowngraded the stock, stating that the merger and the company’s current market share are already baked into the stock price.\nThe company’s earnings alsocontinue to disappointinvestors and analysts. Given that more consolidation and regulatory changes are likely in the broader cannabis sector, investors would be smart to keep TLRY stock on their watchlist for now and be ready to buy shares quickly if it looks like a legitimate breakout occurs.\nOn the date of publication, Joel Baglole did not have (either directly or indirectly) any positions in the securities mentioned in this article.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5034207,"gmtCreate":1624759105810,"gmtModify":1663230103831,"authorId":3558569595001242,"author":{"id":3558569595001242,"authorId":3558569595001242,"name":"Wandakdash","avatar":"https://static.tigerbbs.com/211ec3a66712c46a80ca45e20dbbd8a4","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":198998507,"type":1,"supId":0,"prevId":0,"content":" Naise ","text":" Naise ","html":" Naise "}],"langContent":"EN"},{"id":191451409,"gmtCreate":1620902090401,"gmtModify":1704350146417,"author":{"id":"3582196378161649","authorId":"3582196378161649","name":"Ahliangteh","avatar":"https://static.tigerbbs.com/31a34e59d9c129f49d49b2902d03484b","vip":1,"crmLevel":1,"crmLevelSwitch":0},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/191451409","repostId":1108721806,"repostType":4,"repost":{"id":"1108721806","pubTimestamp":1620899790,"share":"https://www.laohu8.com/m/news/1108721806?lang=&edition=full","pubTime":"2021-05-13 17:56","market":"us","language":"en","title":"Post-Merger Tilray Stock Is One To Keep On Your Watchlist for Now","url":"https://stock-news.laohu8.com/highlight/detail?id=1108721806","media":"InvestorPlace","summary":"More consolidation and regulatory changes are likely coming to the volatile cannabis sector.\n\nCan Ca","content":"<blockquote>\n <b>More consolidation and regulatory changes are likely coming to the volatile cannabis sector.</b>\n</blockquote>\n<p>Can Canadian cannabis producer<b>Tilray</b>(NASDAQ:<b><u>TLRY</u></b>) get its mojo back? Once-hot TLRY stock is down more than 62% over the past three months, compared to the 16.9% decline for pot sector tracker<b>ETFMG Alternative Harvest ETF</b>(NYSEARCA:<b><u>MJ</u></b>). The shares are the top holding in the exchange-traded fund’s (ETF) 31-stock portfolio.</p>\n<p>Investors are hoping that the Toronto-based company can finally turn itself around now that it is officially the biggest Canadian marijuana producer following thecompletion of its mergerwith former rival Aphria.</p>\n<p>The newly merged company, which retains the Tilray name and brand, is now larger than other major cannabis companies such as<b>Canopy Growth</b>(NASDAQ:<b><u>CGC</u></b>) and<b>Aurora Cannabis</b>(NYSE:<b><u>ACB</u></b>) with annual revenues approaching $1 billion and a 17% share of the North American retail cannabis market.</p>\n<p>As the recreational cannabis space continues to evolve, mature and consolidate, shareholders are expecting the newly reinforced Tilray to not only survive but to thrive.</p>\n<p><b>TLRY Stock Highs and Lows</b></p>\n<p>The completed merger with Aphria has given Tilray and its stock a much needed lift. TLRY stock popped 14% immediately following news that the merger had successfully concluded and investment bank<b>Jefferies Group</b>immediatelyupgraded the company’s sharesto “buy” from “underperform,” calling the merger with Aphria a “perfect match” and stating that Tilray has excellent upside potential in terms of future sales in the U.S., Canada and Europe.</p>\n<p>The positive response to the merger was welcome by Tilray shareholders who have been on a wild ride with the stock so far this year. In early February, TLRY stock was targeted for ashort squeezeby the retail investors who commiserate on Reddit. In a concerted effort, they drove Tilray’s share price up 253%, from $25.77 on Jan. 29 to a peak of $90.99 on Feb. 10. The stock was back down to $30 a share by March 5 and today trades at $14.53.</p>\n<p>Sadly, this was not the first time Tilray stock had gotten caught in a short squeeze. The same thinghappened in 2018, when the share price was driven 1,400% higher.</p>\n<p><b>Targeting U.S. Market</b></p>\n<p>Post-merger, Tilray is now being run by the senior leadership team that previously ran Aphria. While the merged company retains the Tilray name, it is now former Aphria CEO Irwin Simon running the show. Former Tilray CEO Brendan Kennedy has relinquished his management role and now serves only on the company’s board of directors.</p>\n<p>Moving forward, Tilray has said its immediate priorities are to finalize the merger internally and to focus its sales efforts onthe U.S. market, where it sees a huge opportunity.</p>\n<p>Simon has said Tilray’s ambition is to eventually control 30% of the North American cannabis market. With moreU.S. states legalizing cannabis(18 states in total have now legalized the drug for recreational use) and hope that the Biden administration may legalize the recreational drug at the federal level, Tilray is eager to expand in the U.S. with an array of products that include cannabis-infused beverages and edibles.</p>\n<p>Outside of North America, the company is expanding its presence in markets such as Germany andentering new marketswhere personal use has been decriminalized, such asIsraeland Portugal.</p>\n<p>Much of Tilray’s international expansion focuses on a mix of recreational and medicinal cannabis products.</p>\n<p><b>Not Yet Stable Investment</b></p>\n<p>A lot continues to happen in the cannabis space and there’s no question that Tilray is a stronger and more resilient company after its merger with Aphria. However, the cannabis sector continues toevolve and changerapidly. A lot still needs to happen before cannabis can be considered a stable and mature investment. And this fact is reflected in TLRY stock, which continues to hover around $15 and struggles to stay above the $20 per share threshold.</p>\n<p>While some investors have upgraded Tilray’s shares in recent weeks, others havedowngraded the stock, stating that the merger and the company’s current market share are already baked into the stock price.</p>\n<p>The company’s earnings alsocontinue to disappointinvestors and analysts. Given that more consolidation and regulatory changes are likely in the broader cannabis sector, investors would be smart to keep TLRY stock on their watchlist for now and be ready to buy shares quickly if it looks like a legitimate breakout occurs.</p>\n<p><i>On the date of publication, Joel Baglole did not have (either directly or indirectly) any positions in the securities mentioned in this article.</i></p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Post-Merger Tilray Stock Is One To Keep On Your Watchlist for Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPost-Merger Tilray Stock Is One To Keep On Your Watchlist for Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-13 17:56 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/05/post-merger-tilray-stock-is-one-to-keep-on-your-watchlist-for-now/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>More consolidation and regulatory changes are likely coming to the volatile cannabis sector.\n\nCan Canadian cannabis producerTilray(NASDAQ:TLRY) get its mojo back? Once-hot TLRY stock is down more than...</p>\n\n<a href=\"https://investorplace.com/2021/05/post-merger-tilray-stock-is-one-to-keep-on-your-watchlist-for-now/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TLRY":"Tilray Inc."},"source_url":"https://investorplace.com/2021/05/post-merger-tilray-stock-is-one-to-keep-on-your-watchlist-for-now/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1108721806","content_text":"More consolidation and regulatory changes are likely coming to the volatile cannabis sector.\n\nCan Canadian cannabis producerTilray(NASDAQ:TLRY) get its mojo back? Once-hot TLRY stock is down more than 62% over the past three months, compared to the 16.9% decline for pot sector trackerETFMG Alternative Harvest ETF(NYSEARCA:MJ). The shares are the top holding in the exchange-traded fund’s (ETF) 31-stock portfolio.\nInvestors are hoping that the Toronto-based company can finally turn itself around now that it is officially the biggest Canadian marijuana producer following thecompletion of its mergerwith former rival Aphria.\nThe newly merged company, which retains the Tilray name and brand, is now larger than other major cannabis companies such asCanopy Growth(NASDAQ:CGC) andAurora Cannabis(NYSE:ACB) with annual revenues approaching $1 billion and a 17% share of the North American retail cannabis market.\nAs the recreational cannabis space continues to evolve, mature and consolidate, shareholders are expecting the newly reinforced Tilray to not only survive but to thrive.\nTLRY Stock Highs and Lows\nThe completed merger with Aphria has given Tilray and its stock a much needed lift. TLRY stock popped 14% immediately following news that the merger had successfully concluded and investment bankJefferies Groupimmediatelyupgraded the company’s sharesto “buy” from “underperform,” calling the merger with Aphria a “perfect match” and stating that Tilray has excellent upside potential in terms of future sales in the U.S., Canada and Europe.\nThe positive response to the merger was welcome by Tilray shareholders who have been on a wild ride with the stock so far this year. In early February, TLRY stock was targeted for ashort squeezeby the retail investors who commiserate on Reddit. In a concerted effort, they drove Tilray’s share price up 253%, from $25.77 on Jan. 29 to a peak of $90.99 on Feb. 10. The stock was back down to $30 a share by March 5 and today trades at $14.53.\nSadly, this was not the first time Tilray stock had gotten caught in a short squeeze. The same thinghappened in 2018, when the share price was driven 1,400% higher.\nTargeting U.S. Market\nPost-merger, Tilray is now being run by the senior leadership team that previously ran Aphria. While the merged company retains the Tilray name, it is now former Aphria CEO Irwin Simon running the show. Former Tilray CEO Brendan Kennedy has relinquished his management role and now serves only on the company’s board of directors.\nMoving forward, Tilray has said its immediate priorities are to finalize the merger internally and to focus its sales efforts onthe U.S. market, where it sees a huge opportunity.\nSimon has said Tilray’s ambition is to eventually control 30% of the North American cannabis market. With moreU.S. states legalizing cannabis(18 states in total have now legalized the drug for recreational use) and hope that the Biden administration may legalize the recreational drug at the federal level, Tilray is eager to expand in the U.S. with an array of products that include cannabis-infused beverages and edibles.\nOutside of North America, the company is expanding its presence in markets such as Germany andentering new marketswhere personal use has been decriminalized, such asIsraeland Portugal.\nMuch of Tilray’s international expansion focuses on a mix of recreational and medicinal cannabis products.\nNot Yet Stable Investment\nA lot continues to happen in the cannabis space and there’s no question that Tilray is a stronger and more resilient company after its merger with Aphria. However, the cannabis sector continues toevolve and changerapidly. A lot still needs to happen before cannabis can be considered a stable and mature investment. And this fact is reflected in TLRY stock, which continues to hover around $15 and struggles to stay above the $20 per share threshold.\nWhile some investors have upgraded Tilray’s shares in recent weeks, others havedowngraded the stock, stating that the merger and the company’s current market share are already baked into the stock price.\nThe company’s earnings alsocontinue to disappointinvestors and analysts. Given that more consolidation and regulatory changes are likely in the broader cannabis sector, investors would be smart to keep TLRY stock on their watchlist for now and be ready to buy shares quickly if it looks like a legitimate breakout occurs.\nOn the date of publication, Joel Baglole did not have (either directly or indirectly) any positions in the securities mentioned in this article.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4316022,"gmtCreate":1620914903323,"gmtModify":1680788568040,"authorId":3582196378161649,"author":{"id":3582196378161649,"authorId":3582196378161649,"name":"Ahliangteh","avatar":"https://static.tigerbbs.com/31a34e59d9c129f49d49b2902d03484b","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":191451409,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"},{"id":4313811,"gmtCreate":1620902653971,"gmtModify":1680788518102,"authorId":3570063321997588,"author":{"id":3570063321997588,"authorId":3570063321997588,"name":"hitithard","avatar":"https://static.tigerbbs.com/309ce7b357018aa7b946332c2fe8725c","vip":1,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-3","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"93.12%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1101},"crmLevel":8,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":191451409,"type":1,"supId":0,"prevId":0,"content":"Comment on my comment","text":"Comment on my comment","html":"Comment on my comment"}],"langContent":"EN"},{"id":191453952,"gmtCreate":1620901855276,"gmtModify":1704350143612,"author":{"id":"3559088164596385","authorId":"3559088164596385","name":"Troedas","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":5,"crmLevelSwitch":0},"htmlText":"Comment and like please. Thank you","listText":"Comment and like please. Thank you","text":"Comment and like please. Thank you","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/191453952","repostId":1108721806,"repostType":4,"repost":{"id":"1108721806","pubTimestamp":1620899790,"share":"https://www.laohu8.com/m/news/1108721806?lang=&edition=full","pubTime":"2021-05-13 17:56","market":"us","language":"en","title":"Post-Merger Tilray Stock Is One To Keep On Your Watchlist for Now","url":"https://stock-news.laohu8.com/highlight/detail?id=1108721806","media":"InvestorPlace","summary":"More consolidation and regulatory changes are likely coming to the volatile cannabis sector.\n\nCan Ca","content":"<blockquote>\n <b>More consolidation and regulatory changes are likely coming to the volatile cannabis sector.</b>\n</blockquote>\n<p>Can Canadian cannabis producer<b>Tilray</b>(NASDAQ:<b><u>TLRY</u></b>) get its mojo back? Once-hot TLRY stock is down more than 62% over the past three months, compared to the 16.9% decline for pot sector tracker<b>ETFMG Alternative Harvest ETF</b>(NYSEARCA:<b><u>MJ</u></b>). The shares are the top holding in the exchange-traded fund’s (ETF) 31-stock portfolio.</p>\n<p>Investors are hoping that the Toronto-based company can finally turn itself around now that it is officially the biggest Canadian marijuana producer following thecompletion of its mergerwith former rival Aphria.</p>\n<p>The newly merged company, which retains the Tilray name and brand, is now larger than other major cannabis companies such as<b>Canopy Growth</b>(NASDAQ:<b><u>CGC</u></b>) and<b>Aurora Cannabis</b>(NYSE:<b><u>ACB</u></b>) with annual revenues approaching $1 billion and a 17% share of the North American retail cannabis market.</p>\n<p>As the recreational cannabis space continues to evolve, mature and consolidate, shareholders are expecting the newly reinforced Tilray to not only survive but to thrive.</p>\n<p><b>TLRY Stock Highs and Lows</b></p>\n<p>The completed merger with Aphria has given Tilray and its stock a much needed lift. TLRY stock popped 14% immediately following news that the merger had successfully concluded and investment bank<b>Jefferies Group</b>immediatelyupgraded the company’s sharesto “buy” from “underperform,” calling the merger with Aphria a “perfect match” and stating that Tilray has excellent upside potential in terms of future sales in the U.S., Canada and Europe.</p>\n<p>The positive response to the merger was welcome by Tilray shareholders who have been on a wild ride with the stock so far this year. In early February, TLRY stock was targeted for ashort squeezeby the retail investors who commiserate on Reddit. In a concerted effort, they drove Tilray’s share price up 253%, from $25.77 on Jan. 29 to a peak of $90.99 on Feb. 10. The stock was back down to $30 a share by March 5 and today trades at $14.53.</p>\n<p>Sadly, this was not the first time Tilray stock had gotten caught in a short squeeze. The same thinghappened in 2018, when the share price was driven 1,400% higher.</p>\n<p><b>Targeting U.S. Market</b></p>\n<p>Post-merger, Tilray is now being run by the senior leadership team that previously ran Aphria. While the merged company retains the Tilray name, it is now former Aphria CEO Irwin Simon running the show. Former Tilray CEO Brendan Kennedy has relinquished his management role and now serves only on the company’s board of directors.</p>\n<p>Moving forward, Tilray has said its immediate priorities are to finalize the merger internally and to focus its sales efforts onthe U.S. market, where it sees a huge opportunity.</p>\n<p>Simon has said Tilray’s ambition is to eventually control 30% of the North American cannabis market. With moreU.S. states legalizing cannabis(18 states in total have now legalized the drug for recreational use) and hope that the Biden administration may legalize the recreational drug at the federal level, Tilray is eager to expand in the U.S. with an array of products that include cannabis-infused beverages and edibles.</p>\n<p>Outside of North America, the company is expanding its presence in markets such as Germany andentering new marketswhere personal use has been decriminalized, such asIsraeland Portugal.</p>\n<p>Much of Tilray’s international expansion focuses on a mix of recreational and medicinal cannabis products.</p>\n<p><b>Not Yet Stable Investment</b></p>\n<p>A lot continues to happen in the cannabis space and there’s no question that Tilray is a stronger and more resilient company after its merger with Aphria. However, the cannabis sector continues toevolve and changerapidly. A lot still needs to happen before cannabis can be considered a stable and mature investment. And this fact is reflected in TLRY stock, which continues to hover around $15 and struggles to stay above the $20 per share threshold.</p>\n<p>While some investors have upgraded Tilray’s shares in recent weeks, others havedowngraded the stock, stating that the merger and the company’s current market share are already baked into the stock price.</p>\n<p>The company’s earnings alsocontinue to disappointinvestors and analysts. Given that more consolidation and regulatory changes are likely in the broader cannabis sector, investors would be smart to keep TLRY stock on their watchlist for now and be ready to buy shares quickly if it looks like a legitimate breakout occurs.</p>\n<p><i>On the date of publication, Joel Baglole did not have (either directly or indirectly) any positions in the securities mentioned in this article.</i></p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Post-Merger Tilray Stock Is One To Keep On Your Watchlist for Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPost-Merger Tilray Stock Is One To Keep On Your Watchlist for Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-13 17:56 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/05/post-merger-tilray-stock-is-one-to-keep-on-your-watchlist-for-now/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>More consolidation and regulatory changes are likely coming to the volatile cannabis sector.\n\nCan Canadian cannabis producerTilray(NASDAQ:TLRY) get its mojo back? Once-hot TLRY stock is down more than...</p>\n\n<a href=\"https://investorplace.com/2021/05/post-merger-tilray-stock-is-one-to-keep-on-your-watchlist-for-now/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TLRY":"Tilray Inc."},"source_url":"https://investorplace.com/2021/05/post-merger-tilray-stock-is-one-to-keep-on-your-watchlist-for-now/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1108721806","content_text":"More consolidation and regulatory changes are likely coming to the volatile cannabis sector.\n\nCan Canadian cannabis producerTilray(NASDAQ:TLRY) get its mojo back? Once-hot TLRY stock is down more than 62% over the past three months, compared to the 16.9% decline for pot sector trackerETFMG Alternative Harvest ETF(NYSEARCA:MJ). The shares are the top holding in the exchange-traded fund’s (ETF) 31-stock portfolio.\nInvestors are hoping that the Toronto-based company can finally turn itself around now that it is officially the biggest Canadian marijuana producer following thecompletion of its mergerwith former rival Aphria.\nThe newly merged company, which retains the Tilray name and brand, is now larger than other major cannabis companies such asCanopy Growth(NASDAQ:CGC) andAurora Cannabis(NYSE:ACB) with annual revenues approaching $1 billion and a 17% share of the North American retail cannabis market.\nAs the recreational cannabis space continues to evolve, mature and consolidate, shareholders are expecting the newly reinforced Tilray to not only survive but to thrive.\nTLRY Stock Highs and Lows\nThe completed merger with Aphria has given Tilray and its stock a much needed lift. TLRY stock popped 14% immediately following news that the merger had successfully concluded and investment bankJefferies Groupimmediatelyupgraded the company’s sharesto “buy” from “underperform,” calling the merger with Aphria a “perfect match” and stating that Tilray has excellent upside potential in terms of future sales in the U.S., Canada and Europe.\nThe positive response to the merger was welcome by Tilray shareholders who have been on a wild ride with the stock so far this year. In early February, TLRY stock was targeted for ashort squeezeby the retail investors who commiserate on Reddit. In a concerted effort, they drove Tilray’s share price up 253%, from $25.77 on Jan. 29 to a peak of $90.99 on Feb. 10. The stock was back down to $30 a share by March 5 and today trades at $14.53.\nSadly, this was not the first time Tilray stock had gotten caught in a short squeeze. The same thinghappened in 2018, when the share price was driven 1,400% higher.\nTargeting U.S. Market\nPost-merger, Tilray is now being run by the senior leadership team that previously ran Aphria. While the merged company retains the Tilray name, it is now former Aphria CEO Irwin Simon running the show. Former Tilray CEO Brendan Kennedy has relinquished his management role and now serves only on the company’s board of directors.\nMoving forward, Tilray has said its immediate priorities are to finalize the merger internally and to focus its sales efforts onthe U.S. market, where it sees a huge opportunity.\nSimon has said Tilray’s ambition is to eventually control 30% of the North American cannabis market. With moreU.S. states legalizing cannabis(18 states in total have now legalized the drug for recreational use) and hope that the Biden administration may legalize the recreational drug at the federal level, Tilray is eager to expand in the U.S. with an array of products that include cannabis-infused beverages and edibles.\nOutside of North America, the company is expanding its presence in markets such as Germany andentering new marketswhere personal use has been decriminalized, such asIsraeland Portugal.\nMuch of Tilray’s international expansion focuses on a mix of recreational and medicinal cannabis products.\nNot Yet Stable Investment\nA lot continues to happen in the cannabis space and there’s no question that Tilray is a stronger and more resilient company after its merger with Aphria. However, the cannabis sector continues toevolve and changerapidly. A lot still needs to happen before cannabis can be considered a stable and mature investment. And this fact is reflected in TLRY stock, which continues to hover around $15 and struggles to stay above the $20 per share threshold.\nWhile some investors have upgraded Tilray’s shares in recent weeks, others havedowngraded the stock, stating that the merger and the company’s current market share are already baked into the stock price.\nThe company’s earnings alsocontinue to disappointinvestors and analysts. Given that more consolidation and regulatory changes are likely in the broader cannabis sector, investors would be smart to keep TLRY stock on their watchlist for now and be ready to buy shares quickly if it looks like a legitimate breakout occurs.\nOn the date of publication, Joel Baglole did not have (either directly or indirectly) any positions in the securities mentioned in this article.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":191466964,"gmtCreate":1620899819358,"gmtModify":1704350118994,"author":{"id":"3579925209341859","authorId":"3579925209341859","name":"FlyHighFly","avatar":"https://static.tigerbbs.com/a610574cab0fe2ee4e79d08d0eb9ce6c","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"Like please","listText":"Like please","text":"Like please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/191466964","repostId":1108721806,"repostType":4,"repost":{"id":"1108721806","pubTimestamp":1620899790,"share":"https://www.laohu8.com/m/news/1108721806?lang=&edition=full","pubTime":"2021-05-13 17:56","market":"us","language":"en","title":"Post-Merger Tilray Stock Is One To Keep On Your Watchlist for Now","url":"https://stock-news.laohu8.com/highlight/detail?id=1108721806","media":"InvestorPlace","summary":"More consolidation and regulatory changes are likely coming to the volatile cannabis sector.\n\nCan Ca","content":"<blockquote>\n <b>More consolidation and regulatory changes are likely coming to the volatile cannabis sector.</b>\n</blockquote>\n<p>Can Canadian cannabis producer<b>Tilray</b>(NASDAQ:<b><u>TLRY</u></b>) get its mojo back? Once-hot TLRY stock is down more than 62% over the past three months, compared to the 16.9% decline for pot sector tracker<b>ETFMG Alternative Harvest ETF</b>(NYSEARCA:<b><u>MJ</u></b>). The shares are the top holding in the exchange-traded fund’s (ETF) 31-stock portfolio.</p>\n<p>Investors are hoping that the Toronto-based company can finally turn itself around now that it is officially the biggest Canadian marijuana producer following thecompletion of its mergerwith former rival Aphria.</p>\n<p>The newly merged company, which retains the Tilray name and brand, is now larger than other major cannabis companies such as<b>Canopy Growth</b>(NASDAQ:<b><u>CGC</u></b>) and<b>Aurora Cannabis</b>(NYSE:<b><u>ACB</u></b>) with annual revenues approaching $1 billion and a 17% share of the North American retail cannabis market.</p>\n<p>As the recreational cannabis space continues to evolve, mature and consolidate, shareholders are expecting the newly reinforced Tilray to not only survive but to thrive.</p>\n<p><b>TLRY Stock Highs and Lows</b></p>\n<p>The completed merger with Aphria has given Tilray and its stock a much needed lift. TLRY stock popped 14% immediately following news that the merger had successfully concluded and investment bank<b>Jefferies Group</b>immediatelyupgraded the company’s sharesto “buy” from “underperform,” calling the merger with Aphria a “perfect match” and stating that Tilray has excellent upside potential in terms of future sales in the U.S., Canada and Europe.</p>\n<p>The positive response to the merger was welcome by Tilray shareholders who have been on a wild ride with the stock so far this year. In early February, TLRY stock was targeted for ashort squeezeby the retail investors who commiserate on Reddit. In a concerted effort, they drove Tilray’s share price up 253%, from $25.77 on Jan. 29 to a peak of $90.99 on Feb. 10. The stock was back down to $30 a share by March 5 and today trades at $14.53.</p>\n<p>Sadly, this was not the first time Tilray stock had gotten caught in a short squeeze. The same thinghappened in 2018, when the share price was driven 1,400% higher.</p>\n<p><b>Targeting U.S. Market</b></p>\n<p>Post-merger, Tilray is now being run by the senior leadership team that previously ran Aphria. While the merged company retains the Tilray name, it is now former Aphria CEO Irwin Simon running the show. Former Tilray CEO Brendan Kennedy has relinquished his management role and now serves only on the company’s board of directors.</p>\n<p>Moving forward, Tilray has said its immediate priorities are to finalize the merger internally and to focus its sales efforts onthe U.S. market, where it sees a huge opportunity.</p>\n<p>Simon has said Tilray’s ambition is to eventually control 30% of the North American cannabis market. With moreU.S. states legalizing cannabis(18 states in total have now legalized the drug for recreational use) and hope that the Biden administration may legalize the recreational drug at the federal level, Tilray is eager to expand in the U.S. with an array of products that include cannabis-infused beverages and edibles.</p>\n<p>Outside of North America, the company is expanding its presence in markets such as Germany andentering new marketswhere personal use has been decriminalized, such asIsraeland Portugal.</p>\n<p>Much of Tilray’s international expansion focuses on a mix of recreational and medicinal cannabis products.</p>\n<p><b>Not Yet Stable Investment</b></p>\n<p>A lot continues to happen in the cannabis space and there’s no question that Tilray is a stronger and more resilient company after its merger with Aphria. However, the cannabis sector continues toevolve and changerapidly. A lot still needs to happen before cannabis can be considered a stable and mature investment. And this fact is reflected in TLRY stock, which continues to hover around $15 and struggles to stay above the $20 per share threshold.</p>\n<p>While some investors have upgraded Tilray’s shares in recent weeks, others havedowngraded the stock, stating that the merger and the company’s current market share are already baked into the stock price.</p>\n<p>The company’s earnings alsocontinue to disappointinvestors and analysts. Given that more consolidation and regulatory changes are likely in the broader cannabis sector, investors would be smart to keep TLRY stock on their watchlist for now and be ready to buy shares quickly if it looks like a legitimate breakout occurs.</p>\n<p><i>On the date of publication, Joel Baglole did not have (either directly or indirectly) any positions in the securities mentioned in this article.</i></p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Post-Merger Tilray Stock Is One To Keep On Your Watchlist for Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPost-Merger Tilray Stock Is One To Keep On Your Watchlist for Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-13 17:56 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/05/post-merger-tilray-stock-is-one-to-keep-on-your-watchlist-for-now/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>More consolidation and regulatory changes are likely coming to the volatile cannabis sector.\n\nCan Canadian cannabis producerTilray(NASDAQ:TLRY) get its mojo back? Once-hot TLRY stock is down more than...</p>\n\n<a href=\"https://investorplace.com/2021/05/post-merger-tilray-stock-is-one-to-keep-on-your-watchlist-for-now/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TLRY":"Tilray Inc."},"source_url":"https://investorplace.com/2021/05/post-merger-tilray-stock-is-one-to-keep-on-your-watchlist-for-now/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1108721806","content_text":"More consolidation and regulatory changes are likely coming to the volatile cannabis sector.\n\nCan Canadian cannabis producerTilray(NASDAQ:TLRY) get its mojo back? Once-hot TLRY stock is down more than 62% over the past three months, compared to the 16.9% decline for pot sector trackerETFMG Alternative Harvest ETF(NYSEARCA:MJ). The shares are the top holding in the exchange-traded fund’s (ETF) 31-stock portfolio.\nInvestors are hoping that the Toronto-based company can finally turn itself around now that it is officially the biggest Canadian marijuana producer following thecompletion of its mergerwith former rival Aphria.\nThe newly merged company, which retains the Tilray name and brand, is now larger than other major cannabis companies such asCanopy Growth(NASDAQ:CGC) andAurora Cannabis(NYSE:ACB) with annual revenues approaching $1 billion and a 17% share of the North American retail cannabis market.\nAs the recreational cannabis space continues to evolve, mature and consolidate, shareholders are expecting the newly reinforced Tilray to not only survive but to thrive.\nTLRY Stock Highs and Lows\nThe completed merger with Aphria has given Tilray and its stock a much needed lift. TLRY stock popped 14% immediately following news that the merger had successfully concluded and investment bankJefferies Groupimmediatelyupgraded the company’s sharesto “buy” from “underperform,” calling the merger with Aphria a “perfect match” and stating that Tilray has excellent upside potential in terms of future sales in the U.S., Canada and Europe.\nThe positive response to the merger was welcome by Tilray shareholders who have been on a wild ride with the stock so far this year. In early February, TLRY stock was targeted for ashort squeezeby the retail investors who commiserate on Reddit. In a concerted effort, they drove Tilray’s share price up 253%, from $25.77 on Jan. 29 to a peak of $90.99 on Feb. 10. The stock was back down to $30 a share by March 5 and today trades at $14.53.\nSadly, this was not the first time Tilray stock had gotten caught in a short squeeze. The same thinghappened in 2018, when the share price was driven 1,400% higher.\nTargeting U.S. Market\nPost-merger, Tilray is now being run by the senior leadership team that previously ran Aphria. While the merged company retains the Tilray name, it is now former Aphria CEO Irwin Simon running the show. Former Tilray CEO Brendan Kennedy has relinquished his management role and now serves only on the company’s board of directors.\nMoving forward, Tilray has said its immediate priorities are to finalize the merger internally and to focus its sales efforts onthe U.S. market, where it sees a huge opportunity.\nSimon has said Tilray’s ambition is to eventually control 30% of the North American cannabis market. With moreU.S. states legalizing cannabis(18 states in total have now legalized the drug for recreational use) and hope that the Biden administration may legalize the recreational drug at the federal level, Tilray is eager to expand in the U.S. with an array of products that include cannabis-infused beverages and edibles.\nOutside of North America, the company is expanding its presence in markets such as Germany andentering new marketswhere personal use has been decriminalized, such asIsraeland Portugal.\nMuch of Tilray’s international expansion focuses on a mix of recreational and medicinal cannabis products.\nNot Yet Stable Investment\nA lot continues to happen in the cannabis space and there’s no question that Tilray is a stronger and more resilient company after its merger with Aphria. However, the cannabis sector continues toevolve and changerapidly. A lot still needs to happen before cannabis can be considered a stable and mature investment. And this fact is reflected in TLRY stock, which continues to hover around $15 and struggles to stay above the $20 per share threshold.\nWhile some investors have upgraded Tilray’s shares in recent weeks, others havedowngraded the stock, stating that the merger and the company’s current market share are already baked into the stock price.\nThe company’s earnings alsocontinue to disappointinvestors and analysts. Given that more consolidation and regulatory changes are likely in the broader cannabis sector, investors would be smart to keep TLRY stock on their watchlist for now and be ready to buy shares quickly if it looks like a legitimate breakout occurs.\nOn the date of publication, Joel Baglole did not have (either directly or indirectly) any positions in the securities mentioned in this article.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":18,"commentSize":5,"repostSize":0,"favoriteSize":1,"likeStatus":false,"favoriteStatus":false}}